These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 36801700

  • 1. PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia.
    Bataller A, Chien KS, Sasaki K, Montalban-Bravo G, Kanagal-Shamanna R, Urrutia S, Almanza-Huante E, Gener-Ricos G, Ravandi F, Jabbour E, Kadia T, Borthakur G, Garcia-Manero G.
    Leuk Res; 2023 Apr; 127():107044. PubMed ID: 36801700
    [No Abstract] [Full Text] [Related]

  • 2. [Role of ASXL1 mutation in myeloid malignancies].
    Sheng MY, Zhou Y, Xu MJ, Yang FC.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1183-7. PubMed ID: 25130853
    [Abstract] [Full Text] [Related]

  • 3. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
    Boultwood J, Perry J, Pellagatti A, Fernandez-Mercado M, Fernandez-Santamaria C, Calasanz MJ, Larrayoz MJ, Garcia-Delgado M, Giagounidis A, Malcovati L, Della Porta MG, Jädersten M, Killick S, Hellström-Lindberg E, Cazzola M, Wainscoat JS.
    Leukemia; 2010 May; 24(5):1062-5. PubMed ID: 20182461
    [No Abstract] [Full Text] [Related]

  • 4. Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.
    Gelsi-Boyer V, Brecqueville M, Devillier R, Murati A, Mozziconacci MJ, Birnbaum D.
    J Hematol Oncol; 2012 Mar 21; 5():12. PubMed ID: 22436456
    [Abstract] [Full Text] [Related]

  • 5. Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
    Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu B.
    Clin Transl Oncol; 2021 Sep 21; 23(9):1731-1742. PubMed ID: 33861431
    [Abstract] [Full Text] [Related]

  • 6. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
    Reinig E, Yang F, Traer E, Arora R, Brown S, Rattray R, Braziel R, Fan G, Press R, Dunlap J.
    Am J Clin Pathol; 2016 Apr 21; 145(4):497-506. PubMed ID: 27124934
    [Abstract] [Full Text] [Related]

  • 7. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
    Damm F, Itzykson R, Kosmider O, Droin N, Renneville A, Chesnais V, Gelsi-Boyer V, de Botton S, Vey N, Preudhomme C, Clavert A, Delabesse E, Park S, Birnbaum D, Fontenay M, Bernard OA, Solary E.
    Leukemia; 2013 Jun 21; 27(6):1401-3. PubMed ID: 23443343
    [No Abstract] [Full Text] [Related]

  • 8. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.
    Huh YO, Tang G, Talwalkar SS, Khoury JD, Ohanian M, Bueso-Ramos CE, Abruzzo LV.
    Cancer Genet; 2016 Jun 21; 209(7-8):313-20. PubMed ID: 27318442
    [Abstract] [Full Text] [Related]

  • 9. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
    Qu SQ, Pan LJ, Qin TJ, Xu ZF, Li B, Wang HJ, Sun Q, Jia YJ, Li CW, Cai WY, Gao QY, Jiao M, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2023 May 14; 44(5):373-379. PubMed ID: 37550186
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia.
    Helbig G, Chromik K, Woźniczka K, Kopińska AJ, Boral K, Dworaczek M, Koclęga A, Armatys A, Panz-Klapuch M, Markiewicz M.
    Pathol Oncol Res; 2019 Jul 14; 25(3):1175-1180. PubMed ID: 30613922
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis.
    Lin Y, Zheng Y, Wang ZC, Wang SY.
    Hematology; 2016 Sep 14; 21(8):454-61. PubMed ID: 27077763
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia.
    Daver N, Strati P, Jabbour E, Kadia T, Luthra R, Wang S, Patel K, Ravandi F, Cortes J, Qin Dong X, Kantarjian H, Garcia-Manero G.
    Am J Hematol; 2013 Jan 14; 88(1):56-9. PubMed ID: 23115106
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
    Ronaghy A, Yang RK, Khoury JD, Kanagal-Shamanna R.
    Curr Hematol Malig Rep; 2020 Jun 14; 15(3):194-202. PubMed ID: 32382988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.